XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
(FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | (FY)Jun 30, 2020 | (FY)Jun 30, 2019 | (FY)Jun 30, 2018 | (FY)Jun 30, 2017 | (FY)Jun 30, 2016 | (FY)Jun 30, 2015 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | -26.23%8.77B | -23.62%11.88B | -36.63%15.55B | 316.95%24.55B | -26.50%5.89B | -25.35%8.01B | -41.47%10.73B | 69.70%18.33B | -50.53%10.8B | 193.10%21.84B |
Operating revenue | -26.23%8.77B | -23.62%11.88B | -36.63%15.55B | 316.95%24.55B | -26.50%5.89B | -25.35%8.01B | -41.47%10.73B | 69.70%18.33B | -50.53%10.8B | 193.10%21.84B |
Cost of revenue | -17.68%5.34B | -11.09%6.49B | -33.68%7.3B | 351.77%11.01B | -30.75%2.44B | -40.06%3.52B | -43.65%5.87B | 71.66%10.42B | -62.15%6.07B | 463.11%16.04B |
Gross profit | -36.52%3.42B | -34.70%5.39B | -39.03%8.25B | 292.35%13.53B | -23.18%3.45B | -7.58%4.49B | -38.60%4.86B | 67.19%7.91B | -18.40%4.73B | 26.03%5.8B |
Operating expense | -3.99%1.08B | 8.41%1.13B | 0.42%1.04B | -0.51%1.04B | -8.33%1.04B | 13.09%1.14B | 5.60%1.01B | -14.71%952.15M | 29.44%1.12B | 3.64%862.39M |
Selling and administrative expenses | -2.55%878M | 3.86%901M | 5.37%867.48M | -2.45%823.28M | -9.47%843.99M | 13.97%932.27M | 5.08%818.03M | -18.67%778.49M | 39.90%957.15M | 2.81%684.17M |
-General and administrative expense | -2.55%878M | 3.86%901M | 5.37%867.48M | -2.45%823.28M | -9.47%843.99M | 13.97%932.27M | 5.08%818.03M | -18.67%778.49M | 39.90%957.15M | 2.81%684.17M |
Other operating expenses | -9.65%206M | 31.08%228M | -18.65%173.94M | 7.77%213.83M | -3.14%198.41M | 9.28%204.85M | 7.95%187.46M | 9.11%173.66M | -10.70%159.15M | 6.98%178.23M |
Operating profit | -45.14%2.34B | -40.92%4.26B | -42.30%7.21B | 419.16%12.5B | -28.22%2.41B | -12.97%3.35B | -44.65%3.85B | 92.46%6.96B | -26.76%3.62B | 30.97%4.94B |
Net non-operating interest income expense | 74.68%2.3B | 324.22%1.32B | -41.77%309.98M | -46.42%532.3M | 70.37%993.44M | 13.87%583.12M | 69.45%512.09M | 2.40%302.21M | -0.96%295.13M | 120.19%297.99M |
Non-operating interest income | 68.22%2.34B | 312.44%1.39B | -41.06%337.26M | -44.19%572.19M | 59.38%1.03B | 13.83%643.25M | 13.49%565.1M | 1.72%497.94M | -2.90%489.49M | 36.92%504.12M |
Non-operating interest expense | -43.42%43M | 178.57%76M | -31.60%27.28M | 25.63%39.89M | -47.20%31.75M | 13.42%60.13M | -72.91%53.01M | 0.70%195.72M | -5.71%194.36M | -11.47%206.13M |
Other net income (expense) | ||||||||||
Special income (charges) | ---- | ---- | ---- | ---- | -16.51%41.62M | -99.29%49.86M | --7.05B | --0 | ---- | ---- |
-Less:Other special charges | ---- | ---- | ---- | ---- | 16.51%-41.62M | 99.29%-49.86M | ---7.05B | ---- | ---- | ---- |
Other non- operating income (expenses) | -1,610.00%-302M | -83.07%20M | -6.66%118.15M | -37.84%126.58M | 117.22%203.64M | -86.73%93.75M | 223.15%706.62M | 139.84%218.67M | 13.73%91.17M | -14.90%80.16M |
Income before tax | -29.24%4.77B | -7.83%6.74B | -43.76%7.31B | 491.18%13.01B | -71.50%2.2B | -50.73%7.72B | 47.59%15.67B | 36.91%10.61B | -27.00%7.75B | 2.87%10.62B |
Income tax | -39.72%519M | -36.18%861M | -46.69%1.35B | 381.85%2.53B | -26.40%525.22M | -56.26%713.65M | -34.94%1.63B | 322.22%2.51B | -48.17%593.97M | -10.54%1.15B |
Net income | -27.70%4.25B | -1.42%5.88B | -43.06%5.96B | 525.46%10.47B | -76.09%1.67B | -50.09%7B | 73.12%14.03B | 13.24%8.11B | -24.44%7.16B | 4.77%9.47B |
Net income continuous Operations | -27.70%4.25B | -1.42%5.88B | -43.06%5.96B | 525.46%10.47B | -76.09%1.67B | -50.09%7B | 73.12%14.03B | 13.24%8.11B | -24.44%7.16B | 4.77%9.47B |
Minority interest income | -587.10%-151M | -86.48%31M | -72.33%229.31M | 6,305.45%828.59M | -114.85%-13.35M | 135.47%89.92M | -94.48%38.19M | 909.88%691.82M | -33.45%68.51M | -15.49%102.94M |
Net income attributable to the parent company | -24.74%4.4B | 1.98%5.85B | -40.54%5.74B | 471.43%9.65B | -75.59%1.69B | -50.59%6.91B | 88.76%14B | 4.57%7.41B | -24.34%7.09B | 5.05%9.37B |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | -24.74%4.4B | 1.98%5.85B | -40.54%5.74B | 471.43%9.65B | -75.59%1.69B | -50.59%6.91B | 88.76%14B | 4.57%7.41B | -24.34%7.09B | 5.05%9.37B |
Basic earnings per share | -28.77%2.6 | -3.95%3.65 | -42.86%3.8 | 454.17%6.65 | -76.70%1.2 | -52.75%5.15 | 83.19%10.9 | 2.59%5.95 | -25.11%5.8 | 3.75%7.745 |
Diluted earnings per share | -28.77%2.6 | -3.95%3.65 | -42.86%3.8 | 454.17%6.65 | -76.70%1.2 | -52.74%5.15 | 83.15%10.8972 | 2.59%5.95 | -25.11%5.8 | 3.75%7.745 |
Dividend per share | 0.97%2.8953 | 2.67%2.8675 | 1.52%2.7929 | -0.07%2.751 | 1.61%2.753 | 2.39%2.7093 | 3.78%2.6461 | -0.09%2.5497 | 46.29%2.5521 | -25.60%1.7445 |
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |